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The direct genetic modification of adenoviral capsid proteins with new ligands is an attractive means to confer targeted tropism to adenoviral
vectors. Although several capsid proteins have been reported to tolerate the genetic fusion of foreign peptides and proteins, direct comparison of
cell targeting efficiencies through the different capsomeres has been lacking. Likewise, direct comparison of with one or multiple ligands has not
been performed due to a lack of capsid-compatible ligands available for retargeting. Here we utilize a panel of metabolically biotinylated Ad
vectors to directly compare targeted transduction through the fiber, protein IX, and hexon capsomeres using a variety of biotinylated ligands
including antibodies, transferrin, EGF, and cholera toxin B. These results clearly demonstrate that cell targeting with a variety of high affinity
receptor-binding ligands is only effective when transduction is redirected through the fiber protein. In contrast, protein IX and hexon-mediated
targeting by the same set of ligands failed to mediate robust vector targeting, perhaps due to aberrant trafficking at the cell surface or inside
targeted cells. These data suggest that vector targeting by genetic incorporation of high affinity ligands will likely be most efficient through
modification of the adenovirus fiber rather than the protein IX and hexon capsomeres. In contrast, single-step monomeric avidin affinity
purification of Ad vectors using the metabolic biotinylation system is most effective through capsomeres like protein IX and hexon.
© 2006 Elsevier Inc. All rights reserved.Keywords: Adenovirus vector targeting; Vector purification; Fiber; Protein IX; Hexon; Metabolic biotinylationIntroduction
Adenoviral (Ad) vectors have great potential for use in gene
therapy and gene-based vaccines. Targeting of Ad vectors to
therapeutically relevant tissue and cell types in vivo could
greatly improve their safety and performance by lowering the
effective dosage required for therapeutic levels of gene
expression. Redirection of Ad vector tropism will require
physical modifications of the adenoviral capsid and genetic
modification of the Ad capsid represents an attractive approach⁎ Corresponding author. One Baylor Plaza, BCM505, Houston, TX 77030,
USA. Fax: +1 713 798 1481.
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doi:10.1016/j.virol.2006.01.032towards targeting Ad vectors (Barry et al., 2003; Mizuguchi and
Hayakawa, 2004).
The Ad virion is a non-enveloped icosahedral particle
composed of 12 distinct polypeptides, seven of which form the
outer capsid structure. Trimers of hexon, the most abundant
structural protein, form the near-planar facets of the icosahedral
shell with pentons occupying positions at each of the 12
vertices. Each penton consists of five copies of the penton base
from which the trimeric fiber protrudes approximately 300 Å
away from the capsid. Four other “minor” capsid proteins
including IIIa, VI, VIII, and IX also contribute to the capsid
structure (Rux and Burnett, 2004).
In vitro work has demonstrated that the initial attachment of
Ad5 is mediated by the high affinity binding (Kd = 15 nM) of
the distal knob domain of the adenoviral fiber to cell surface
coxsackievirus B and adenovirus receptor (CAR), a type 1
transmembrane protein in the immunoglobulin superfamily
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heparan sulfate glycosaminoglycans (HS-GAGs) have been
speculated to promote virion attachment to certain cell types
(Smith et al., 2002, 2003). Although the mechanisms of in vivo
attachment and uptake are poorly understood, they may involve
interactions between lysine–lysine–threonine–lysine (KKTK)
motifs present within the Ad5 fiber shaft and cell surface HS-
GAGs in addition to CAR-mediated infection (Smith et al.,
2002, 2003). Secondary interactions between exposed argi-
nine–glycine–aspartatic acid (RGD) motifs present within
surface loops of the penton base and cell surface αvβ1, αvβ3,
αvβ5, or α3β1 integrins promote uptake through clathrin-
mediated endocytosis (Li et al., 2001; Salone et al., 2003;
Wickham et al., 1993). This classical model of Ad5 uptake has
recently been elaborated and new data suggest that the binding
of additional blood factors can greatly influence vector uptake
(Shayakhmetov et al., 2005).
Receptor binding and uptake of Ad5 occur relatively
quickly, with the majority (80–85%) of the bound virions
being taken up within 5–10 min (Greber et al., 1993). During
uptake, the Ad5 virion undergoes a process of disassembly,
beginning with the release of upwards of 90% of the fibers
during the early stages of entry (Greber et al., 1993). Once the
virion has been taken up, the natural process of endosomal
acidification triggers a conformational change in the Ad5
capsid, ultimately resulting in endosomolysis and release of the
virion into the cytoplasm. Recently, it has been shown that
protein VI contains an N-terminal amphipathic α-helical
domain that possesses the membrane lytic activity responsible
for endosomal escape (Wiethoff et al., 2005). The current
working model suggests that the Ad capsid somehow senses the
decrease in pH and responds by releasing various vertex
components including the peripentonal hexons, protein IIIa, and
protein VI. Upon release, the N-terminal amphipathic α-helical
domain of VI becomes free to disrupt the endosomal membrane
(Wiethoff et al., 2005). Again, the process of endosomal escape
is believed to occur relatively rapid, with the majority of virions
reaching the cytoplasm by 15–20 min post-infection (Greber et
al., 1993).
Once free in the cytoplasm, the partially dismantled capsid
interacts with dynein, a cytoplasmic motor protein (Kelkar et
al., 2004). The association of Ad5 with dynein enables the
virions to translocate along microtubules towards the microtu-
bule organizing center (MTOC) eventually accumulating
around the host cell nucleus (Bailey et al., 2003). Previous
work has demonstrated specific interactions between the Ad5
capsid and cell nuclei using both in vitro binding assays as well
as direct visualization with electron microscopy (Wisnivesky et
al., 1999). More detailed analysis has revealed that Ad
specifically binds to the CAN/Nup214 protein of the nuclear
pore complex (NPC) and this association leads to further
disassembly and eventual import of the adenoviral genome into
the nucleus (Strunze et al., 2005; Trotman et al., 2001). Overall,
the entire process from initial cell surface binding to docking at
the NPC is rapid and usually occurs within 30–60 min
depending on the cell type and morphology (Greber et al.,
1993).In recent years, several locales have been identified within
the Ad capsid that tolerate the display of foreign peptides and
proteins. Foreign peptides ranging from short epitopes to
protein domains have successfully been grafted into the surface
exposed HI loop (Belousova et al., 2002; Dmitriev et al., 1998;
Reynolds et al., 1999) and C-terminus (Bouri et al., 1999;
Parrott et al., 2003) of the fiber knob domain, the RGD-
containing loop of penton base (Wickham et al., 1995), the
hypervariable region 5 (HVR5) surface loop of hexon
(Crompton et al., 1994; Vigne et al., 1999), and the C-terminus
of protein IX (Campos et al., 2004; Dmitriev et al., 2002;
Vellinga et al., 2004). Various degrees of successful vector
targeting have been reported by the modification of these Ad
capsid proteins, but there has never been a direct head to head
comparison of vector targeting through the different Ad
capsomeres. In addition, comparisons of different ligands at
different capsomeres have been largely restricted to testing of
the RGD integrin-binding peptide due to a lack of available
ligands that are compatible with direct genetic engineering into
the capsid proteins.
Recently, we have shown that metabolically biotinylated Ad
vectors can be created by fusion of the biotin acceptor peptide
(BAP) from the biotin-dependent transcarboxylase enzyme of
Propionibacterium shermanii to the C-terminus of the fiber
protein (Parrott et al., 2003) and protein IX (Campos et al., 2004)
or by insertion into hypervariable region 5 (HVR5) of the hexon
protein (Campos and Barry, 2004) (Fig. 1). During propagation
in 293A cells, these BAP modified capsid proteins are
metabolically biotinylated by the endogenous biotin–protein
ligase holocarboxylase synthetase, resulting in virions that
display covalently attached biotin molecules at different
locations on the surface of the icosahedral capsid. These vectors
not only display biotins at different capsid sites, but also have the
potential to display varied numbers of biotins and biotinylated
ligands per virions, since fiber, protein IX, and hexon are present
in 36, 240, and 720 copies, respectively. Given this repertoire of
capsomeres and ligand attachment sites, we utilize this panel of
metabolically biotinylated (Ad-BAP) vectors and the avidin–
biotin interaction to directly compare targeted transduction
through the fiber, protein IX, and hexon capsomeres using a
variety of biotinylated targeting ligands. The avidin-based
purification of these Ad-BAP vectors is also explored.Results
Metabolically biotinylated Ad vectors
The fiber, protein IX, and hexon proteins are present at
different copy numbers and at different positions within the
adenoviral icosahedron. Incorporation of the BAP within the
different structural proteins of the Ad capsid should therefore
result in different magnitudes and positions of biotin display.
Ad-fiber-BAP, Ad-IX-BAP, Ad-IX-45-BAP, and Ad-hexon-
BAP vectors expressing the DsRed2 red fluorescent protein
(Fig. 1) were produced in previous work (Campos and Barry,
2004). While fiber, protein IX, and hexon display of the BAP
Fig. 1. Diagram of the different Ad vectors used in this study. (A) Ad-wt, (B)
Ad-fiber-BAP, (C) Ad-IX-BAP, (D) Ad-IX-45-BAP, and (E) Ad-hexon-BAP all
contain the DsRed fluorescent reporter gene in the E1 region under control of the
CMV promoter. Ad-IX-45-BAP contains a 45 Å alpha-helical spacer peptide
derived from the human ApoE4 cDNA between the C-terminus of protein IX
and the BAP domain. Inclusion of this spacer has shown to improve peptide
display from the C-terminus of IX leading to enhanced CAR-independent
targeted transduction through IX-45-RGD fusions (Vellinga et al., 2004).
Fig. 2. Ad-BAP vectors display biotin and are functional for CAR-mediated
transduction. (A) Biotin quantification assay of the Ad-BAP vectors. Avidin–
HRP binding of the Ad-BAP vectors was quantified by ELISA and these signals
were compared to a standard curve of known biotin concentrations, resulting in
an approximation of biotin display. Values are reported as mean calculations of
triplicate experiments ± standard deviation. (B) Transduction of Ad-BAP
vectors. CAR-positive HeLa cells were transduced with each vector at the
indicated MOI and mean fluorescence intensity (MFI) was measured 48 h later
by flow cytometry. Values are reported as the mean MFI of triplicate
experiments ± standard deviation.
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overexpression of these viral structural components during Ad
vector production (Walters et al., 2002) might prevent full
saturation of the BAPs with biotin due to the possibly limited
amounts of endogenous holocarboxylase synthetase.
To quantitate the number of actual biotins on the virions of
these vectors, ELISA with avidin–horseradish peroxidase
(avidin–HRP) was used to compare the relative extent of
biotinylation (Fig. 2A). These results generally agreed with the
known relative stoichiometry of the capsid proteins with Ad-
fiber-BAP displaying the lowest number of biotins, Ad-IX-BAP
displaying an intermediate amount, and Ad-hexon-BAP having
the highest number of surface biotins. When compared to a
standard curve of known biotinylated protein, the estimated
number of biotins for Ad-fiber-BAP, Ad-IX-BAP, and Ad-
hexon-BAP was approximately 36, 70, and 245 biotins per
virion (Fig. 2A). This corresponded to approximately 100%,
30%, and 34% of the maximum number of biotins possible for
each of the capsomeres. This result was not entirely unexpected,
since this ELISA assay is based on the ability of large avidin–
HRP molecules (approximately 90 kDa) to bind to accessible
biotins on the virions. Therefore, if biotins were displayed near
to each other (e.g. on protein IX or hexon), or were occluded by
nearby structures, steric hindrance might prevent binding of
avidin–HRP to underestimate the total number of free biotins.When an additional 45 Å alpha-helical spacer was engineered
between the protein IX C-terminus and the BAP, the extension
further increased the detectable biotins on the virions nearly 2-
fold (Fig. 2A). This was consistent with previous results where
in the same 45 Å, spacer on protein IX also increased
transduction by virions displaying the RGD motif over those
lacking the spacer (Vellinga et al., 2004). These data therefore
indicated that Ad-fiber-BAP displays 36 biotins, whereas Ad-
IX-BAP, Ad-IX-45-BAP, and Ad-hexon-BAP display at least
70, 130, and 245 biotins, but may display more biotins than can
be detected by this assay.
Transduction by untargeted Ad-BAPs
Transduction of CAR-positive HeLa was used to determine
the effects of the BAP modification on CAR-dependent vector
binding, uptake, and gene delivery. Cells were transduced with
each Ad vector at various multiplicities of infection (MOI) and
transduction was quantified by measurement of red fluorescent
protein expression by flow cytometry (Fig. 2B). Results show a
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protein IX and hexon-modified vectors transduced HeLa cells to
levels similar to unmodified Ad vector (Fig. 2B). The decrease
observed for Ad-fiber-BAP is consistent with previous
observations (Parrott et al., 2003) and is most likely due to
the C-terminal addition of the BAP precluding the interaction
between the fiber and cell surface CAR.
Avidin-based purification of Ad-BAP vectors
In a previous work, we demonstrated the ability to affinity
purify Ad-fiber-BAP on monomeric avidin columns (Parrott et
al., 2003). The use of an affinity-based method for vector
purification is an attractive alternative to traditional CsCl
density gradient centrifugation, especially for very small or
large-scale preparations that cannot be effectively banded by
CsCl-based techniques. Monomeric avidin has a greatly
reduced affinity for biotin (Kd = 10
−7 M) than the tetrameric
form (Kd = 10
−14 M) and supports the reversible binding and
gentle elution of biotinylated adenovirus using biotin (Parrott et
al., 2003).
We demonstrated that while Ad-Fiber-BAP could be purified
by this approach, less than 30% of virion bioactivity was
recovered from the affinity resin after single-step monomeric
avidin purification from 100 mm dish cell lysates (Parrott et al.,
2003). We hypothesized that Ad-IX-BAP, Ad-IX-45-BAP, and
Ad-hexon-BAP might be more effectively purified than Ad-
fiber-BAP, since these display approximately 2, 4, and 7 timesFig. 3. Avidin-based purification of Ad-BAP vectors. (A) Quantification of vector bi
and flow cytometry. (B) SDS-PAGE and Coomassie staining (top) of input (lane 1) a
proteins by Coomassie except for the abundance of free hexon-BAP protein. Wester
Positions of the BAP fusions are marked with symbols. (C) Coomassie-stained gel o
loaded in the control lane. Note the relative absence of core proteins.as many biotin molecular tags. To test this, 100 mm plates of
293A cells were infected at low MOI with control and
biotinylated vectors, the cells were harvested 3–4 days later,
and the resulting crude lysates were incubated in batch format
with monomeric avidin resin in a tube. Unbound lysate was
removed, the resin was washed five times, and bound vector
was eluted twice with 5 mM biotin. Fractions were collected
and then analyzed for vector bioactivity by transduction of
HeLa cells (Fig. 3A). Unmodified Ad-wt vector exhibited weak
non-specific binding to the resin, with the majority of the
bioactivity disappearing by the second wash. In contrast, all
varieties of BAP-modified vectors bound tightly to the resin
with b1% bioactivity present in the unbound and wash
fractions. Elution with 5 mM biotin resulted in the release of
all of the Ad-BAP vectors, but not the control vector. When
vector recovery was quantitated by flow cytometry, nearly
100% of the bioactivity of both the IX and hexon-modified
vectors were recovered from the avidin after biotin elution (Fig.
3A). In contrast, biotin elution of Ad-fiber-BAP recovered only
30–35% of the input bioactivity, consistent with previous work
(Parrott et al., 2003).
To determine the purity of the vectors by this single-step
affinity purification, equivalent volumes of various fractions
were analyzed for protein content by SDS-PAGE and Western
blot (Fig. 3B). Comparison of the input and elution fractions for
each sample revealed that the majority of cellular proteins were
indeed removed during the purification. Because this was a
purification from only one 100 mm dish of infected cells, theoactivity present in each of the fractions as measured by HeLa cell transduction
nd elution (lane 2) fractions. Elution fractions were too dilute to visualize capsid
n blot of the identical gel (bottom), probed with anti-[Ad5] polyclonal antibody.
f concentrated elution fractions. 3 × 109 VP of a CsCl-purified Ad-wt prep was
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to observe by Coomassie blue staining in the elutions fractions
(Fig. 3B). In contrast, virion proteins were observed in con-
centrated elutions (Fig. 3C) and by more sensitive Western blot
(Fig. 3B, lower panel). However, Coomassie blue staining and
Western blot analysis revealed that not only were the biotin-
tagged virions recovered, but each of the biotin-tagged
capsomeres were also co-purified with the vectors (Figs. 3B–
C). For example, elution of Ad-hexon-BAP resulted in the co-
purification of massive amounts of free hexon-BAP protein, as
seen by the Coomassie-stained gel (Fig. 3B, upper panel).
Likewise, Western blotting demonstrated co-purification of
biotinylated fiber with Ad-fiber-BAP virions and co-purification
of biotinylated protein IX with Ad-IX-45-BAP virions (Fig. 3B,
lower panel). This was not unexpected since Ad capsid proteins
are produced in excess over the small amount that is actually
encapsidated during infection (Walters et al., 2002).
This co-purification of tagged capsomeres explains the
reduced bioactivity of Ad-fiber-BAP after biotin elution. Any
fiber that co-purifies with the virions has the potential to
compete for virion binding to CAR or to HS-GAG's. In
contrast, neither protein IX nor hexon is thought to mediate cell
binding and should not compete for vector binding to the cells.
Therefore, even though Coomassie and Western blotting
demonstrate that Ad-fiber-BAP can bind and elute from
monomeric avidin just as effectively as the IX and hexon-
modified vectors, the co-purified excess fiber-BAP in the
elution fraction likely competes for binding and transduction by
Ad-fiber-BAP when assayed on HeLa cells. Dialysis with 0.3 to
1 MDa dialysis membranes or passage of the lysates through 1
MDa exclusion gel filtration columns prior to monomeric avidin
purification will likely provide a simple means to remove these
contaminating free capsomeres from this affinity purification
approach. Alternately, one could use this as an approach to
purify the capsomeres themselves.
One major disadvantage of any affinity method for
adenoviral purification (i.e. ion exchange, avidin, etc.) is that
these methods cannot separate empty and immature particles
from fully assembled infectious virions. In contrast, intact
particles can be readily separated from empty particles on CsCl
gradients. Comparison of the avidin-purified biotinylated
vectors CsCl-purified wild-type Ad5 demonstrated that the
purity of some of the monomeric avidin fractions was close to
that of the CsCl method (Fig. 3C). As expected, this affinity
method was unable to separate empty virions as evidenced by
the skewed ratios of the capsid proteins and the notable
absence of detectable core proteins (Fig. 3C). The avidin-
purified Ad-fiber-BAP was relatively clean with the exception
of the large amounts of free fiber-BAP. Avidin-purified Ad-
hexon-BAP was the least pure, containing massive amounts of
free hexon-BAP and many smaller species including a large
amount of the 27 kDa immature pVI, a protein known to
interact tightly with hexon trimers (Wodrich et al., 2003). Of
the avidin-purified vectors, the protein IX-labeled virus
appeared most optimal as compared to the CsCl preparation,
since it had lower levels of tagged capsomere contamination.
This lower contamination is likely due to the lower level ofprotein IX produced in infected cells as compared to the
massive levels of both hexon and fiber.
Ligand-targeted transduction of Ad-BAP vectors
The display of biotin molecules on the surface of the Ad
virion allows one to attach any biotinylated ligand to the vectors
with a tetrameric avidin bridge for vector targeting. This panel
of metabolically biotinylated BAP-modified vectors allowed
the opportunity for the direct comparison of ligand-mediated
retargeting of Ad vectors through different capsid proteins. We
hypothesized that vector targeting through protein IX and hexon
might be more efficient than that by Ad-fiber-BAP, given that
Ad-IX-BAP, Ad-IX-45-BAP, and Ad-hexon-BAP display
roughly 2, 4, and 7 times as many avidin-accessible biotin
molecules than the fiber-modified vector (Fig. 2A). To test this,
CAR-negative K562 cells were used for their low background
of Ad5 transduction as in (Parrott et al., 2003). K562 cells
express high levels of cell surface CD59, a glycosyl
phosphatidyl inositol (GPI) linked complement regulatory
protein, as well as CD71, the transferrin receptor (Parrott et
al., 2003). Cells were labeled by saturation with biotinylated
antibodies against CD59 and CD71, as well as the cognate
ligand transferrin, followed by extensive washing and saturation
with avidin, thereby converting cell surface CD59 and CD71
into potential Ad vector receptors through the extremely strong
avidin–biotin interaction. Cells were then incubated with
metabolically biotinylated vectors and transduction was
assessed 48 h later by fluorescence microscopy (Fig. 4A).
Surprisingly, while 75% the K562 cells were effectively
transduced through all of ligand–receptor pairs with Ad-fiber-
BAP, transduction was not enhanced by the same ligands with
Ad-IX-BAP, Ad-IX-45-BAP, or with Ad-hexon-BAP.
A431 cells, another CAR-negative refractory human cell
line, were similarly tested for ligand-targeted gene delivery.
A431 cells express very high levels of the epidermal growth
factor receptor (EGFR), in addition to moderate levels of CD59
and CD71. Transduction of metabolically biotinylated Ad
vectors was evaluated using biotinylated epidermal growth
factor (EGF), anti-CD59, anti-CD71, and transferrin as
targeting ligands. Quantification of DsRed transduction by
flow cytometry again revealed that Ad-Fiber-BAP was efficient
with a wide variety of ligands resulting in 30–50-fold
enhancement in the percent positive cells (Fig. 4B) and 40–
60-fold increases in overall transduction as measured by total
fluorescence (Fig. 4C). In contrast, ligand-mediated transduc-
tion through the more abundant protein IX or hexon proteins
produced very little increases in transduction with the same
ligands.
Additional experiments were performed on partially differ-
entiated murine C2C12 myoblasts. This cell line, derived from
mouse skeletal muscle, is low for CAR expression and can be
differentiated by serum deprivation, leading to the fusion of
cells into multinucleated fibers, reminiscent of muscle tissue.
Cultures of these myotubes were established and transduced
with the BAP-modified vectors. Flow cytometry of labeled
myoblasts had previously shown that these cells express high
Fig. 4. Comparison of ligand-targeted transduction of refractory cells through fiber, protein IX, and hexon. (A) CAR-negative K562 cells were transduced with the Ad-
BAP vectors at 5000 MOI through the indicated ligands and DsRed expression was assessed 48 h later by fluorescence microscopy. (B, C) Comparison of Ad-BAP
transduction of refractory A431 cells at 5000 MOI through biotinylated protein and antibody ligands. Quantification of the fold-increase in transduction efficiency (B)
and the fold-increase in DsRed fluorescence (C), as compared to untargeted vectors. Results are presented as the mean values of three experiments ± standard
deviation. (D) Refractory murine C2C12 cells were transduced with the Ad-BAP vectors at the indicated MOI in the presence or absence of biotinylated CTx-B and
DsRed expression was visualized 48 h post-transduction by fluorescence microscopy. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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brightly with the cholera toxin B subunit (CTx-B) that binds this
ganglioside with high affinity. When this alternate biotinylated
ligand was tested, transduction by Ad-fiber-BAP was again
very efficient, resulting in transduction of nearly 85% of the
cells (Fig. 4D). In contrast, transduction of Ad-IX-BAP and Ad-
hexon-BAP was weak through CTx-B, even at the higher MOIs
(Fig. 4D). These data indicate that the fiber capsomere of Ad is a
substantially more efficient scaffold for ligand display than
either protein IX or hexon, at least in the context of the
metabolic biotinylation system.
To further investigate the differences in transduction through
fiber or protein IX, CTx-B targeted binding and trafficking was
analyzed by fluorescence microscopy. Purified Ad-fiber-BAP
and Ad-IX-BAP virions were covalently labeled with the bright
orange/red fluorophore amine-reactive Alexafluor 555 succini-
midyl ester. 555-labeled vectors were separated from the excess
free dye by CsCl banding and desalting through a 10 kDa size
exclusion column. This modification produced no significantdifferences in infectivity between the fluorophore conjugated
and unlabeled vectors (data not shown). Cell binding and entry
were then tested by the fluorescent virions on C2C12 cells that
were plated on microscope chamber slides. Each vector was
targeted by conjugation to CTx-B on the C2C12 cells. Half of
the samples were maintained at 4 °C to visualize binding and the
other half of the samples were shifted to 37 °C for 45 min to
observe intracellular trafficking of the vectors. Samples were
then fixed, stained with DAPI, and visualized by fluorescence
deconvolution microscopy.
At the initial timepoint, both the fiber and IX-BAP vectors
were found bound similarly to the cell surfaces of the cells (Fig.
5). Shifting the temperature to 37 °C for 45 min resulted in the
accumulation of Ad-fiber-BAP within the cytoplasm and at the
nuclear periphery of the cells, in a patter similar to that observed
during CAR-mediated uptake of fluorescently labeled Ad5
vectors (Miyazawa et al., 1999). In contrast, targeting Ad-IX-
BAP with CTx-B led to aberrant trafficking after 45 min where
there was accumulation of the 555-labeled vector as bright
Fig. 5. Fluorescence deconvolution microscopy of the binding and internaliza-
tion of AlexaFluor 555-labeled Ad-BAP vectors (red) through biotinylated CTx-
B on murine C2C12 myoblasts. Nuclei were stained with DAPI (blue).
Representative micrographs are shown.
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the C2C12 cells (Fig. 5). This altered trafficking pattern may
explain the non-productive transduction observed by ligand-
targeted Ad-IX-BAP as compared to Ad-fiber-BAP.
Discussion
Metabolic biotinylation of the adenoviral capsid has for the
first time enabled a direct comparison of ligand-mediated cell
targeting through the fiber, IX, and hexon capsomeres with a
variety of ligands targeting multiple receptors. This work
reveals that although biotin display and avidin-based purifica-
tion are possible through any of the modified capsid proteins,
transduction is only efficiently redirected through the fiber
protein. Fiber has evolved as the natural cell binding protein of
the Ad capsid and inefficient transduction results from the
redirection of binding and uptake through other capsid
components. This work suggests that future efforts should be
focused on modification of the fiber protein or its analogs for
ligand-mediated vector targeting, or on the re-engineering
protein IX and hexon to recapitulate the biology of fiber after
vector entry.
Protein IX has received much attention lately as a useful
locale for the display of large polypeptides from the adenoviral
capsid (Parks, 2005). Direct genetic fusion of large targeting
ligands to the C-terminus of IX is an attractive alternative to
fiber modification for the introduction of targeted tropism into
Ad vectors. Hexon also represents an appealing candidate for
the introduction of new tropism, due to the sheer abundance of
the protein within the virion. Regardless of the multivalent
biotin display achieved through fusion of the BAP to the IX and
hexon capsomeres, these vectors are quite ineffective for avidin-
based redirection of transduction through a variety of ligand–
receptor interactions. In contrast, Ad-fiber-BAP is an extremely
versatile platform for ligand-mediated cell targeting through theavidin–biotin system. Ad-fiber-BAP transduction can be
targeted to a wide range of refractory cells through a broad
array of ligands (Fig. 4 and Parrott et al., 2003), despite the fact
that it displays the fewest amount of biotins per capsid.
Although the exact mechanisms responsible for the
observed differences in capsomere retargeting have not been
determined, our current working hypothesis relies on the
inherent functional differences between fiber and the other
capsomeres during vector uptake and trafficking. The orches-
trated dissociation of the fibers and other vertex components
(i.e. penton base and protein VI) from virions in the endosome
is well documented (Greber et al., 1993; Wiethoff et al., 2005).
Our targeting data with fiber, protein IX, and hexon suggest
that this fiber and vertex shedding is not only important for
proper endosomal lysis, but may also be important for efficient
release of the virion from high affinity interactions with its cell
surface receptor (Fig. 6A). Since fiber is designed by evolution
to release from virions at this stage, high affinity ligands
attached to it via the biotin–avidin interaction are also shed
from the virions allowing the virus to escape from the
endosome, enter the cytoplasm, and traffic to the nucleus. In
contrast, neither protein IX nor hexon release from the virions
until after reaching the nucleus (Greber et al., 1993;
Meulenbroek et al., 2004). Therefore, conjugation of the vector
to cell surface receptors via high affinity interactions (i.e.
antibodies, growth factors, etc.) via protein IX or hexon may
result in entrapment of the virions on receptors preventing the
virions from trafficking to the nucleus (Figs. 5 and 6B). These
“trapped” virions may either remain in the endosomal
compartments to be destroyed in the lysosomes, or may be
recycled back to the cell surface, depending on innate receptor
biology. This model applies to high affinity ligands. Previous
work using small lower affinity peptides like poly-lysine on
protein IX and RGD in hexon demonstrated increased
transduction (Dmitriev et al., 2002; Vellinga et al., 2004;
Vigne et al., 1999). While these provide proof of principle for
low affinity ligand targeting with protein IX and hexon, this
work did not directly compare the efficiency of the same ligand
on the other capsomeres, so it is unclear if fiber display of the
same ligand in the same work would show similarly higher
efficiency as shown in our work. Also, since Ad5 already binds
integrins via RGD in penton base and may bind HS-GAGs
through the fiber, the addition of more integrin binding or HS-
GAG binding motifs via RGD and poly-lysine makes teasing
out the specific role of new ligand display difficult with these
ligands. Work is underway to determine if conjugation or
genetic engineering of non-RGD/poly-lysine lower affinity
peptide ligands to protein IX and hexon allows these scaffolds
to be effective, since these lower affinity ligands may
themselves release from receptors in the endosomes due to
their weaker interactions. Protein IX and hexon may indeed
serve as useful locales for the attachment of other functional
domains like GFP or thymidine kinase (Li et al., 2005;
Meulenbroek et al., 2004) for particle tracking, immunomod-
ulatory domains for the repression of host innate immune
responses, or fusogenic peptides and nuclear localization
signals to enhance intracellular trafficking of vector particles.
Fig. 6. Proposed model of targeted transduction mediated through the various capsomeres. (A) Receptor binding and uptake through the fiber protein results in normal
trafficking and efficient transduction because of fiber release. (B) Receptor binding and uptake through protein IX and hexon may result in altered trafficking and poor
transduction due to the entrapment of targeted virions on their bound receptors.
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affinity ligand targeting, these capsomeres are more useful than
the fiber as scaffolds for single-step monomeric avidin
purification of the vectors. While monomeric avidin purification
was not as clean as CsCl, it is a simple, single-step batch
purification in a tube which contrasts with the longer, more
laborious CsCl gradient spins in ultracentrifuges. In addition,
unlike CsCl, this method is scaleable in both directions. In this
example, virions were purified from a single 100 mm dish of
cells. This amount of virus would be too small for purification by
CsCl. We anticipate that monomeric avidin, like other affinity
purification approaches will also be more scaleable towards the
higher end of large virus preparations than CsCl. If higher purity
is desired, monomeric avidin could be combined with dialysis or
other methods to remove the tagged free capsomeres from the
preparation before or after purification on monomeric avidin.
Alternately, monomeric avidin can be used after one CsCl
banding to replace a second CsCl spin as well as the traditional
desalting columns to remove salt and protein contaminants. The
first CsCl spin should enrich for intact particles while depleting
free biotinylated capsomeres, while the monomeric avidin
column should remove salts and non-biotinylated contaminates.
Unlike the traditional size-exclusion desalting column that
dilutes the sample, the monomeric avidin affinity approach
should maintain or increase virion concentration. In addition,
this affinity approach can be performed in batch mode in a
sterile tube reducing contamination that can occur in column
formats or in HPLC or FPLC instruments. Work is underway
to determine if these monomeric avidin purification strategies
will have utility for GMP purification of first-generation and
helper-dependent adenoviral vectors.
In summary, this work demonstrates that the fiber capsomere
is the most efficient scaffold for ligand display using a variety of
high affinity ligands against a variety of cell surface receptors,
at least in the context of biotin–avidin targeting. This represents
the first systematic comparison of capsomeres and ligands for
targeting efforts. We also show that fiber, protein IX, and hexon
can all be used for affinity purification of virions on monomericavidin, but that protein IX provides the cleanest single-step
purification platform.
Materials and methods
Cell transduction
HeLa cells were plated to 80% confluence in a 24 well plate
and transduced in triplicate with each vector at multiplicities of
infection (MOI) of 5000, 500, and 50 VP/cell for 2 h in a
minimal volume of DMEM plus 2% FBS. Vector was removed
and 2 ml of fresh cDMEMwas added to each well. Transduction
was measured 48 h post-transduction by flow cytometry. 10,000
events were counted and the mean fluorescence intensity (MFI)
versus MOI was plotted for each vector.
ELISA
All washes and incubations performed at 4 °C unless
otherwise stated. Serial dilutions of each vector in PBS were
adsorbed onto the wells of a high-binding microtiter plate for 3
h. The plate was then blocked with TBST plus 5% milk for 3 h.
100 μl of NeutrAvidin-HRP (2 μg/ml in PBS) was added to each
well and the plate was incubated for an additional 2 h. The plate
was washed extensively and bound HRP was detected by
colorimetric reaction with 100 μl tetramethylbenzidine substrate
for 30 min at room temperature. The reaction was stopped by
the addition of 50 μl 1.8 M H2SO4 and absorbance at 450 nM
was measured with an automated microplate reader.
Biotin quantification
Metabolically biotinylated recombinant maltose binding
protein (MBP-biotin, Avidity Inc.) with a known MBP:biotin
stoichiometry of 1:1, was diluted to 1 μg/ml in PBS and various
amounts ranging from 1–12 ng were immobilized on the wells
of a microtiter plate. The different amounts of biotin were then
quantified for NeutrAvidin-HRP binding as described above.
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allowed a standard curve of biotin content versus A450 to be
plotted. Serial 2-fold dilutions ranging from 5 × 108 VP to
1.56 × 107 VP were quantified for avidin binding by ELISA as
described above. Comparison of average A450 values from the
known amounts of vector to those of the MBP-biotin standard
curve resulted in the approximation of the number of biotin
molecules per capsid of each BAP-modified vector.
Purification on monomeric avidin resin
Softlink monomeric avidin resin (Promega) was pre-
adsorbed with biotin and regenerated according to the
manufacturer's protocol. Resin was pre-blocked with 2.5%
BSA and equilibrated in buffer A195 (Evans et al., 2004). 293A
cells were plated in 100 mm dishes, grown to 80% confluence,
and infected with each vector at an MOI of 50 VP/cell. Cells
were harvested 3–4 days post-infection, once they displayed
complete cytopathic effect. Cells were washed twice in buffer
A195 and lysed in 10 ml A195 by three freeze/thaw cycles.
Lysate was centrifuged and 500 μl of monomeric avidin resin
was added to 9 ml of the supernatant and incubated for 4 h on an
orbital shaker. Resin was pelleted and washed 5× with 10 ml of
A195. All unbound and wash fractions were stored. Vector was
eluted overnight by the addition of 4 ml A195 containing 5 mM
d-biotin. The elution fraction was collected and a second 2
h elution was performed. All washes and incubations were
performed at 4 °C. Aliquots of each fraction were assayed for
bioactivity on HeLa cells and for protein content by SDS-PAGE
and Western blotting.
Ligand-targeted transduction of suspension cells
K562 erythroid leukemia cells were maintained in cDMEM.
5 × 105 cells were aliquoted into 5 ml round bottom polystyrene
tubes and pelleted by gentle centrifugation. Cells were washed
twice in 2 ml Hank's balanced salt solution with 1% BSA
(HBSS-BSA) and pelleted. Cells were incubated in 250 μl of a
1:50 dilution of biotinylated cell targeting ligand in HBSS-BSA
for 20 min with occasional mixing. Cells were then washed
three twice in 2 ml HBSS-BSA and incubated in 500 μl of
NeutrAvidin (100 μg/ml) in HBSS-BSA for 20 min. Cells were
washed twice in HBSS-BSA and incubated with vectors at an
MOI of 5000 VP/cell for 20 min. Cells were then washed 3
times in HBSS-BSA and plated in 1 ml cDMEM at 37 °C. All
washes and incubations were performed at 4 °C. All
concentrations of ligands and avidin were at saturating levels.
Transduction was assessed 24–48 h later by fluorescence
microscopy and/or flow cytometry.
Ligand-targeted transduction of adherent cells
Adherent cells (A431, C2C12) were plated in 24 well plates
and grown overnight in the appropriate growth medium. Cells
were washed twice in HBSS-BSA and incubated in 250 μl of
various ligands diluted 1:50 in HBSS-BSA as described above.
Cell monolayers were thoroughly washed and incubated withexcess avidin in 250 μl as described above. Cell monolayers
were washed again and incubated with Ad vectors at various
MOI's in 250 μl, as described above. After thorough washing,
cell monolayers were rescued with complete media and
incubated at 37 °C. All washes and incubations were performed
at 4 °C. Transduction was assessed 24–48 h later by
fluorescence microscopy and/or flow cytometry.
Fluorescent virion cell binding
Purified Ad-fiber-BAP and Ad-IX-BAP (5 × 1011 VP) were
labeled with amine-reactive Alexafluor-555 succinimidyl ester
at 40 μg dye per 1012 virions, as recommended by the
manufacturer (Molecular Probes). Excess dye was removed by
banding on a CsCl gradient. Banded vector was desalted and
stored at −80 °C in A195 buffer. Addition of the 555 fluorescent
label caused no significant decreases in transduction on HeLa
cells (data not shown). C2C12 cells were sparsely plated in
permanox 4-chamber slides and attached overnight. Cells were
targeted with biotinylated CTx-B at an MOI of 10,000 vp/cell as
described above, and shifted to 37 °C for 0 or 45 min to allow
uptake of 555-labelled vector. Cells were then washed
extensively to remove unbound vector and samples were
processed for fluorescent microscopy as described below.
Fluorescence deconvolution microscopy
Samples, plated in permanox 4-chamber slides, were
thoroughly washed in PBS and fixed in 10% formalin for 20
min at 4 °C. Samples were washed once in PBS plus 30 mM
glycine and twice in PBS at room temperature prior to
mounting. Samples were permeabilized in PBS plus 0.1%
Triton X-100 for 5 min at room temperature, washed twice in
PBS and mounted in VectaShield containing DAPI (Vector
Laboratories). Specimens were visualized at 100× magnifica-
tion under oil immersion with a Zeiss Axioplan II fluorescence
microscope using the appropriate filter sets. Images were
processed using the MetaMorph software package and
deconvolution was performed using the “no neighbors”
algorithm.
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